Zentalis Pharmaceuticals, Inc. (ZNTL) › Operating IncomeZentalis Pharmaceuticals, Inc. (ZNTL) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$46.84M2020: -$118.79M2021: -$216.54M2022: -$227.29M2023: -$299.51M2024: -$191.19M2025: -$152.81M-$152.81M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$152.81M+20.1%2024-$191.19M+36.2%2023-$299.51M-31.8%2022-$227.29M-5.0%2021-$216.54M-82.3%2020-$118.79M-153.6%2019-$46.84M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share